NASDAQ:AGRX
Agile Therapeutics Stock News
$0.415
+0 (+0%)
At Close: May 07, 2024
Agile Therapeutics: Billion Dollar Buy-Out Is On The Horizon
12:45pm, Friday, 01'st May 2020
Agile Therapeutics is currently trading substantially below its fair value of $6.36/shr on a stand-alone basis. Agile's leading drug, Twirla, is much more valua
Agile Therapeutics to Host First Quarter 2020 Financial Results and Business Update Conference Call on Tuesday, May 5, 2020
11:30am, Thursday, 23'rd Apr 2020
Agile Therapeutics, Inc. (AGRX), a forward-thinking women’s healthcare company, today announced it will report first quarter 2020 financial results after the market close on Tuesday, May 5, 2020. F
Spectrum Pharmaceuticals Appoints Seth H.Z. Fischer to Board of Directors
11:00am, Thursday, 23'rd Apr 2020
Spectrum Pharmaceuticals Appoints Seth H.Z. Fischer to Board of Directors
Agile Therapeutics nominates Sharon Barbari to board of directors AGRX;CYTK;GILD
12:47pm, Wednesday, 22'nd Apr 2020
Agile Therapeutics nominates Sharon Barbari to board of directors AGRX CYTK GILD
Agile Therapeutics Announces Changes to its Board of Directors
12:00pm, Wednesday, 22'nd Apr 2020
Agile Therapeutics, Inc. (AGRX), a forward-thinking women’s healthcare company, today announced that the company has nominated Sharon Barbari for election as a class III director to replace Abhijeet
Agile Therapeutics (AGRX) Flat As Market Sinks: What You Should Know
09:50pm, Wednesday, 01'st Apr 2020
Agile Therapeutics (AGRX) closed at $1.86 in the latest trading session, marking no change from the prior day.
Agile Therapeutics (AGRX) Flat As Market Sinks: What You Should Know
12:00am, Wednesday, 01'st Apr 2020Week 14 MDA Breakout Forecast: Short-Term Picks To Give You An Edge
07:37pm, Saturday, 28'th Mar 2020
Two sample Breakout Stocks for Week 14 with better than 10% short-term upside potential. The MDA Breakout portfolio is up +11.10% YTD compared to the S&P 500 -2
RBC Capital Keeps a Buy Rating on Agile Therapeutics (AGRX)
02:47pm, Wednesday, 25'th Mar 2020
In a report released today, Randall Stanicky from RBC Capital reiterated a Buy rating on Agile Therapeutics (AGRX), with a price target of $8.00. The
RBC Capital Keeps a Buy Rating on Agile Therapeutics (AGRX)
02:47pm, Wednesday, 25'th Mar 2020
In a report released today,
Randall Stanicky
from RBC Capital reiterated a
Buy
rating on Agile Therapeutics (
AGRX
–
Research Report
), with a price target of
$8.00
. The company’s shares closed l
Analysts Offer Insights on Healthcare Companies: Agile Therapeutics (AGRX) and Vir Biotechnology (VIR)
02:21pm, Wednesday, 25'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Agile Therapeutics (AGRX) and Vir Biotechnology (VIR) with
Analysts Offer Insights on Healthcare Companies: Agile Therapeutics (NASDAQ: AGRX) and Vir Biotechnology (NASDAQ: VIR)
02:21pm, Wednesday, 25'th Mar 2020
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Agile Therapeutics (
AGRX
–
Research Report
) and Vir Biotechnology (
VIR
–
Research Report
) with
Agile Therapeutics (AGRX) Stock Remains a Top Pick, Says Analyst
08:31pm, Monday, 23'rd Mar 2020
Over the last month, shares of micro-cap biotech Agile Therapeutics (AGRX) have crashed by an alarming 55%. Following such a remarkable decline, you would think the company must be in real trouble, bu
Agile Therapeutics (AGRX) Stock Remains a Top Pick, Says Analyst
08:28pm, Monday, 23'rd Mar 2020
Over the last month, shares of micro-cap biotech Agile Therapeutics (AGRX) have crashed by an alarming 55%. Following such a remarkable decline, you would
Analysts Are Bullish on These Healthcare Stocks: Avid Bioservices (CDMO), Agile Therapeutics (AGRX)
11:16am, Friday, 20'th Mar 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Avid Bioservices (CDMO), Agile Therapeutics (AGRX) and
